We hypothesize that the selected combination successfully eradicated the tumor in three mice, but it is likely that “dormant” cancer cells persisted in the remaining two mice due to ongoing MYCN expression, allowing these cells to evade the treatment and cause the observed relapses (Figure 3k). The gene discussed is MYCN; the disease is cancer.